Soleus Capital Management

Latest statistics and disclosures from Soleus Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Soleus Capital Management

Companies in the Soleus Capital Management portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr Ser Tr S&p Biotech Put Option (XBI) 52.5 $398M NEW 2.8M 140.78
Bioatla (BCAB) 14.3 $108M NEW 3.2M 34.01
Essa Pharma Com New (EPIX) 3.7 $28M +30% 2.4M 11.93
Galecto (GLTO) 2.5 $19M NEW 1.5M 12.51
Iveric Bio (ISEE) 1.5 $11M -5% 1.6M 6.91
Invitae (NVTA) 1.4 $10M NEW 245k 41.81
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) 1.3 $10M +45% 742k 13.49
C4 Therapeutics Com Stk (CCCC) 1.2 $8.9M NEW 269k 33.13
Ionis Pharmaceuticals Note 0.125%12/1 (Principal) 1.1 $8.7M NEW 8.5M 1.02
Xenon Pharmaceuticals (XENE) 1.1 $8.6M +11% 558k 15.38
Exelixis (EXEL) 1.0 $7.8M NEW 391k 20.07
Natera (NTRA) 1.0 $7.4M -26% 74k 99.52
Vericel (VCEL) 1.0 $7.3M -32% 237k 30.88
Inhibrx (INBX) 0.9 $7.0M -47% 214k 32.97

Setup an alert

Soleus Capital Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Iradimed (IRMD) 0.9 $6.9M +52% 304k 22.80
Tcr2 Therapeutics Inc cs (TCRR) 0.8 $6.2M -29% 200k 30.93
Dariohealth Corp Com New (DRIO) 0.8 $5.7M NEW 402k 14.29
Mersana Therapeutics (MRSN) 0.7 $5.5M -47% 207k 26.61
Lyra Therapeutics (LYRA) 0.7 $5.2M +312% 456k 11.40
Silverback Therapeutics (SBTX) 0.7 $5.0M NEW 108k 46.34
Vesper Healthcare Acqstn Cor Com Cl A (VSPR) 0.6 $4.7M NEW 417k 11.31
Novocure Ord Shs (NVCR) 0.6 $4.3M -52% 25k 173.05
Oaktree Acquisition Corp Shs Cl A 0.5 $4.1M NEW 282k 14.60
SurModics (SRDX) 0.5 $4.0M +20% 93k 43.52
Misonix (MSON) 0.5 $3.8M +20% 301k 12.50
Astrazeneca Sponsored Adr (AZN) 0.4 $3.2M +598% 64k 50.00
Dex (DXCM) 0.4 $3.0M +7% 8.2k 369.63
Alexion Pharmaceuticals (ALXN) 0.4 $3.0M -37% 19k 156.25
Itamar Med Sponsored Ads (ITMR) 0.4 $2.8M 141k 19.86
Establishment Labs Holdings Ord (ESTA) 0.3 $2.5M NEW 67k 37.64
Gossamer Bio Note 5.000% 6/0 (Principal) 0.3 $2.5M +175% 2.8M 0.90
Neogenomics Com New (NEO) 0.3 $2.5M NEW 46k 53.84
Rafael Hldgs Com Cl B (RFL) 0.3 $2.4M 105k 23.32
Merck & Co (MRK) 0.3 $2.3M +6% 28k 81.81
Turning Point Therapeutics I (TPTX) 0.3 $2.3M NEW 19k 121.86
Abbvie (ABBV) 0.3 $2.3M NEW 22k 107.14
Eiger Biopharmaceuticals (EIGR) 0.3 $2.3M -60% 186k 12.29
Compass Pathways Sponsored Ads (CMPS) 0.3 $2.0M -72% 43k 47.63
Oncorus (ONCR) 0.2 $1.8M NEW 56k 32.33
Provention Bio (PRVB) 0.2 $1.8M -24% 106k 16.94
Mirati Therapeutics (MRTX) 0.2 $1.7M NEW 7.8k 219.70
Oak Street Health (OSH) 0.2 $1.7M -53% 28k 61.17
Nevro (NVRO) 0.2 $1.7M -19% 9.6k 173.12
Crispr Therapeutics Namen Akt (CRSP) 0.2 $1.7M +6% 11k 153.07
Trillium Therapeutics Com New (TRIL) 0.2 $1.5M -7% 104k 14.71
Adverum Biotechnologies (ADVM) 0.2 $1.5M -62% 136k 10.84
Kadmon Hldgs (KDMN) 0.2 $1.4M +67% 336k 4.15
Miragen Therapeutics Com New 0.2 $1.3M NEW 81k 16.44
Pieris Pharmaceuticals (PIRS) 0.2 $1.3M 500k 2.50
Scholar Rock Hldg Corp (SRRK) 0.2 $1.2M NEW 25k 48.52
Zymeworks (ZYME) 0.1 $1.1M -74% 23k 47.28
Cardiff Oncology (CRDF) 0.1 $1.0M -79% 57k 17.99
Biogen Idec (BIIB) 0.1 $955k -66% 3.9k 244.93
Horizon Therapeutics Pub L SHS (HZNP) 0.1 $926k -75% 13k 73.17
Revance Therapeutics (RVNC) 0.1 $882k -25% 31k 28.33
Medicenna Therapeutics Corp. (MDNA) 0.1 $874k -24% 187k 4.68
Kymera Therapeutics (KYMR) 0.1 $813k -14% 13k 61.99
Biohaven Pharmaceutical Holding (BHVN) 0.1 $657k NEW 7.7k 85.76
Krystal Biotech (KRYS) 0.1 $625k NEW 10k 59.96
Fate Therapeutics (FATE) 0.1 $621k -29% 6.8k 90.92
Axogen (AXGN) 0.1 $605k -74% 34k 17.89
Alpine Immune Sciences (ALPN) 0.1 $517k NEW 41k 12.59
Protara Therapeutics Com Stk (TARA) 0.1 $390k -83% 16k 24.23
Oaktree Acquisition Corp *w Exp 99/99/999 0.0 $358k NEW 92k 3.90
Staar Surgical Com Par $0.01 (STAA) 0.0 $261k -78% 3.3k 79.09

Past Filings by Soleus Capital Management

SEC 13F filings are viewable for Soleus Capital Management going back to 2019